AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Research | Open Access

Transcriptome alterations and therapeutic drugs in different organs after spinal cord injury based on integrated bioinformatic analysis

Department of Neurosurgery, National Center for Neurological Disorders, Neurosurgical Institute of Fudan University, Shanghai Clinical Medical Center of Neurosurgery, Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Huashan Hospital, Fudan University, Shanghai 200040, China
Department of Nursing, Huashan Hospital, Fudan University, Shanghai 200032, China
Department of Neurosurgery, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610054, Sichuan, China

1 These authors contributed equally to this work.

Show Author Information

Abstract

Objective

To identify transcriptomic alterations and therapeutic drugs in different organs after spinal cord injury via comprehensive bioinformatics analyses.

Methods

RNA-sequencing data of the soleus muscle, bladder, liver, raphe, and sensorimotor cortex areas in various rat spinal cord injury models were obtained from the Gene Expression Omnibus database for bioinformatics analysis. Then, the common pathways and biological pathway changes in multiple organs were identified.

Results

By comparing the enrichment results of differentially expressed genes, inflammatory response and lipid metabolism were found to be significantly altered in multiple organs. The MAPK signaling pathway was a key pathway in the abovementioned biological processes. In addition, autonomous repair was observed in each organ. Finally, pharmacological analysis showed that coenzyme A might be an effective drug.

Conclusion

Coenzyme A is a candidate treatment drug for spinal cord injury. Hence, in addition to the current mechanisms targeted by anti-inflammatory approaches, lipid metabolism can also be a treatment target for spinal cord injury.

Electronic Supplementary Material

Download File(s)
jnrt-11-2-100056-esm1.docx (5.6 MB)

References

1

Hutson TH, Di Giovanni S. The translational landscape in spinal cord injury: focus on neuroplasticity and regeneration. Nat Rev Neurol. 2019;15(12):732-745.

2

Dias DO, Kim H, Holl D, et al. Reducing pericyte-derived scarring promotes recovery after spinal cord injury. Cell. 2018;173(1):153-165. e22.

3

Vajn K, Plunkett JA, Tapanes-Castillo A, et al. Axonal regeneration after spinal cord injury in zebrafish and mammals: differences, similarities, translation. Neurosci Bull. 2013;29(4):402-410.

4

Sharma HS, Chopp M, Chen L, et al. The 2021 yearbook of neurorestoratology. J Neurorestoratol. 2022;10(3), 100008.

5

Huang HY, Chen L, Moviglia G, et al. Advances and prospects of cell therapy for spinal cord injury patients. J Neurorestoratol. 2022;10(1):13-30.

6

Guo XD, Feng YP, Sun TS, et al. Clinical guidelines for neurorestorative therapies in spinal cord injury (2021 China version). J Neurorestoratol. 2021;9(1):31-49.

7

Sun X, Jones ZB, Chen XM, et al. Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship. J Neuroinflammation. 2016;13(1):260.

8

Stark R, Grzelak M, Hadfield J. RNA sequencing: the teenage years. Nat Rev Genet. 2019;20(11):631-656.

9

Pope SD, Medzhitov R. Emerging principles of gene expression programs and their regulation. Mol Cell. 2018;71(3):389-397.

10

Nagatomi J, DeMiguel F, Torimoto K, et al. Early molecular-level changes in rat bladder wall tissue following spinal cord injury. Biochem Biophys Res Commun. 2005;334(4):1159-1164.

11

Tester NJ, Fuller DD, Fromm JS, et al. Long-term facilitation of ventilation in humans with chronic spinal cord injury. Am J Respir Crit Care Med. 2014;189(1):57-65.

12

Gill LC, Ross HH, Lee KZ, et al. Rapid diaphragm atrophy following cervical spinal cord hemisection. Respir Physiol Neurobiol. 2014;192:66-73.

13

Davis S, Meltzer PS. GEOquery: a bridge between the gene expression omnibus (GEO) and BioConductor. Bioinformatics. 2007;23(14):1846-1847.

14

Kolde R, Laur S, Adler P, et al. Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics. 2012;28(4):573-580.

15

Wang W, Xu SW, Zhu XY, et al. Identification and validation of a novel RNA-binding protein-related gene-based prognostic model for multiple myeloma. Front Genet. 2021;12, 665173.

16

Ashburner M, Ball CA, Blake JA, et al. Gene Ontology: tool for the unification of biology. Nat Genet. 2000;25(1):25-29.

17

Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27-30.

18

Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545-15550.

19

Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498-2504.

20

Liu JW, Yu ZJ, Sun ML, et al. Identification of cancer/testis antigen 2 gene as a potential hepatocellular carcinoma therapeutic target by hub gene screening with topological analysis. Oncol Lett. 2019:4778-4788.

21

Stover J, Nagatomi J. Cyclic pressure stimulates DNA synthesis through the PI3K/Akt signaling pathway in rat bladder smooth muscle cells. Ann Biomed Eng. 2007;35(9):1585-1594.

22

Ai K, Liu Q, Xu M, et al. Effect of electroacupuncture on urodynamics of neurogenic bladder and PACAP/cAMP/PKA signaling pathway in detrusor tissue of rats after suprasacral spinal cord injury (in Chinese). Zhen Ci Yan Jiu. 2021;46(9):728-734.

23

Shimizu N, Wada N, Shimizu T, et al. Role of p38 MAP kinase signaling pathways in storage and voiding dysfunction in mice with spinal cord injury. Neurourol Urodyn. 2020;39(1):108-115.

24

Bao F, Brown A, Dekaban GA, et al. CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury. Exp Neurol. 2011;231(2):272-283.

25

Yates AG, Jogia T, Gillespie ER, et al. Acute IL-1RA treatment suppresses the peripheral and central inflammatory response to spinal cord injury. J Neuroinflammation. 2021;18(1):15.

26

Anthony DC, Couch Y. The systemic response to CNS injury. Exp Neurol. 2014;258:105-111.

27

Karsy M, Hawryluk G. Modern medical management of spinal cord injury. Curr Neurol Neurosci Rep. 2019;19(9):65.

28

Liu NK, Xu XM. Phospholipase A2 and its molecular mechanism after spinal cord injury. Mol Neurobiol. 2010;41(2):197-205.

29

Hall ED, Springer JE. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRX. 2004;1(1):80-100.

30

Figueroa JD, Serrano-Illan M, Licero J, et al. Fatty acid binding protein 5 modulates docosahexaenoic acid-induced recovery in rats undergoing spinal cord injury. J Neurotrauma. 2016;33(15):1436-1449.

31

Baazm M, Behrens V, Beyer C, et al. Regulation of inflammasomes by application of Omega-3 polyunsaturated fatty acids in a spinal cord injury model. Cells. 2021;10(11):3147.

32

Wojdasiewicz P, Poniatowski ŁA, Turczyn P, et al. Significance of Omega-3 fatty acids in the prophylaxis and treatment after spinal cord injury in rodent models. Mediat Inflamm. 2020;2020:1-11.

33

Georgieva M, Wei YT, Dumitrascuta M, et al. Fatty acid suppression of glial activation prevents central neuropathic pain after spinal cord injury. Pain. 2019;160(12):2724-2742.

34

Shang FF, Zhao W, Zhao Q, et al. Upregulation of eIF-5A1 in the paralyzed muscle after spinal cord transection associates with spontaneous hindlimb locomotor recovery in rats by upregulation of the ErbB, MAPK and neurotrophin signal pathways. J Proteonomics. 2013;91:188-199.

35

Wei L, Cai GY, Jiang L, et al. Identification of key pathways and RNAs associated with skeletal muscle atrophy after spinal cord injury. J Musculoskelet Neuronal Interact. 2021;21(4):550-559.

36

Krämer DK, Ahlsén M, Norrbom J, et al. Human skeletal muscle fibre type variations correlate with PPAR alpha, PPAR delta and PGC-1 alpha mRNA. Acta Physiol. 2006;188(3/4):207-216.

37

O’Brien LC, Chen Q, Savas J, et al. Skeletal muscle mitochondrial mass is linked to lipid and metabolic profile in individuals with spinal cord injury. Eur J Appl Physiol. 2017;117(11):2137-2147.

38

Long YC, Kostovski E, Boon H, et al. Differential expression of metabolic genes essential for glucose and lipid metabolism in skeletal muscle from spinal cord injured subjects. J Appl Physiol. 2011;110(5):1204-1210.

39

Gillissen G, Schumacher M, Breuer-Werle M. Modulation of antimicrobial effects of beta-lactams by amino acids in vitro. Zentralbl Bakteriol. 1991;275(2):223-232.

40

Mehmet E, Çevik Ö, Akakın D, et al. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury. Prostag Other Lipid Mediat. 2012;99(3/4):131-139.

41

Goodus MT, McTigue DM. Hepatic dysfunction after spinal cord injury: a vicious cycle of central and peripheral pathology? Exp Neurol. 2020;325, 113160.

42

Goodus MT, Carson KE, Sauerbeck AD, et al. Liver inflammation at the time of spinal cord injury enhances intraspinal pathology, liver injury, metabolic syndrome and locomotor deficits. Exp Neurol. 2021;342, 113725.

43

Chariker JH, Ohri SS, Gomes C, et al. Activity/exercise-induced changes in the liver transcriptome after chronic spinal cord injury. Sci Data. 2019;6:88.

44

Liu XH, Graham ZA, Harlow L, et al. Spinal cord injury reduces serum levels of fibroblast growth factor-21 and impairs its signaling pathways in liver and adipose tissue in mice. Front Endocrinol. 2021;12, 668984.

45

Geremia NM, Hryciw T, Bao F, et al. The effectiveness of the anti-CD11d treatment is reduced in rat models of spinal cord injury that produce significant levels of intraspinal hemorrhage. Exp Neurol. 2017;295:125-134.

46

Lossinsky AS, Shivers RR. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review Histol Histopathol. 2004;19(2):535-564.

47

Xie ZP, Huang SX, Xie SK, et al. Potential correlation between depression-like behavior and the mitogen-activated protein kinase pathway in the rat hippocampus following spinal cord injury. World Neurosurg. 2021;154:e29-e38.

48

Badner A, Hacker J, Hong J, et al. Splenic involvement in umbilical cord matrix-derived mesenchymal stromal cell-mediated effects following traumatic spinal cord injury. J Neuroinflammation. 2018;15(1):1-12.

49

Bao F, Omana V, Brown A, et al. The systemic inflammatory response after spinal cord injury in the rat is decreased by α4β1 integrin blockade. J Neurotrauma. 2012;29(8):1626-1637.

50

Weaver LC, Bao F, Dekaban GA, et al. CD11d integrin blockade reduces the systemic inflammatory response syndrome after traumatic brain injury in rats. Exp Neurol. 2015;271:409-422.

Journal of Neurorestoratology
Article number: 100056
Cite this article:
Dong H, Shi D, Bao Y, et al. Transcriptome alterations and therapeutic drugs in different organs after spinal cord injury based on integrated bioinformatic analysis. Journal of Neurorestoratology, 2023, 11(2): 100056. https://doi.org/10.1016/j.jnrt.2023.100056

718

Views

5

Crossref

5

Web of Science

5

Scopus

Altmetrics

Received: 11 February 2023
Revised: 27 March 2023
Accepted: 17 April 2023
Published: 09 May 2023
© 2023 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Return